Literature DB >> 32812096

Voluntarily reported prescribing, monitoring and medication transfer errors in intensive care units in The Netherlands.

B E Bosma1,2, N G M Hunfeld3,4, E Roobol-Meuwese5, T Dijkstra6, S M Coenradie7, A Blenke8, W Bult9,10, P H G J Melief11, M Perenboom-Van Dixhoorn11, P M L A van den Bemt3,9.   

Abstract

Background Medication errors occur frequently in intensive care units (ICU). Voluntarily reported medication errors form an easily available source of information. Objective This study aimed to characterize prescribing, monitoring and medication transfer errors that were voluntarily reported in the ICU, in order to reveal medication safety issues. Setting This retrospective data analysis study included reports of medication errors from eleven Dutch ICU's from January 2016 to December 2017. Method We used data extractions from the incident reporting systems of the participating ICU's. The reports were transferred into one database and categorized into type of error, cause, medication (groups), and patient harm. Descriptive statistics were used to calculate the proportion of medication errors and the distribution of subcategories. Based on the analysis, ICU medication safety issues were revealed. Main outcome measure The main outcome measure was the proportion of prescribing, monitoring and medication transfer error reports. Results Prescribing errors were reported most frequently (n = 233, 33%), followed by medication transfer errors (n = 85, 12%) and monitoring errors (n = 27, 4%). Other findings were: medication transfer errors frequently caused serious harm, especially the omission of home medication involving the central nervous system and proton pump inhibitors; omissions and dosing errors occurred most frequently; protocol problems caused a quarter of the medication errors; and medications needing blood level monitoring (e.g. tacrolimus, vancomycin, heparin and insulin) were frequently involved. Conclusion This analysis of voluntarily reported prescribing, monitoring and medication transfer errors warrants several improvement measures in these processes, which may help to increase medication safety in the ICU.

Entities:  

Keywords:  Incident reporting system; Intensive care unit; Medication error; Medication safety; Patient safety; The Netherlands; Voluntarily reports

Year:  2020        PMID: 32812096     DOI: 10.1007/s11096-020-01101-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


  43 in total

1.  Adverse drug events in intensive care units: risk factors, impact, and the role of team care.

Authors:  Sandra L Kane-Gill; Judith Jacobi; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2010-06       Impact factor: 7.598

2.  A comparison of voluntarily reported medication errors in intensive care and general care units.

Authors:  S L Kane-Gill; J G Kowiatek; R J Weber
Journal:  Qual Saf Health Care       Date:  2010-02

3.  Medication review by a clinical pharmacist at the transfer point from ICU to ward: a randomized controlled trial.

Authors:  A Heselmans; J van Krieken; S Cootjans; K Nagels; D Filliers; K Dillen; S De Broe; D Ramaekers
Journal:  J Clin Pharm Ther       Date:  2015-08-12       Impact factor: 2.512

4.  The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care.

Authors:  Jeffrey M Rothschild; Christopher P Landrigan; John W Cronin; Rainu Kaushal; Steven W Lockley; Elisabeth Burdick; Peter H Stone; Craig M Lilly; Joel T Katz; Charles A Czeisler; David W Bates
Journal:  Crit Care Med       Date:  2005-08       Impact factor: 7.598

5.  Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units.

Authors:  D J Cullen; B J Sweitzer; D W Bates; E Burdick; A Edmondson; L L Leape
Journal:  Crit Care Med       Date:  1997-08       Impact factor: 7.598

6.  An analysis of patient safety incidents associated with medications reported from critical care units in the North West of England between 2009 and 2012.

Authors:  A N Thomas; R J Taylor
Journal:  Anaesthesia       Date:  2014-05-08       Impact factor: 6.955

7.  A review of patient safety incidents reported as 'severe' or 'death' from critical care units in England and Wales between 2004 and 2014.

Authors:  A N Thomas; J J MacDonald
Journal:  Anaesthesia       Date:  2016-07-26       Impact factor: 6.955

8.  Medication-related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency.

Authors:  A N Thomas; U Panchagnula
Journal:  Anaesthesia       Date:  2008-07       Impact factor: 6.955

9.  Selected medical errors in the intensive care unit: results of the IATROREF study: parts I and II.

Authors:  Maité Garrouste-Orgeas; Jean François Timsit; Aurelien Vesin; Carole Schwebel; Patrick Arnodo; Jean Yves Lefrant; Bertrand Souweine; Alexis Tabah; Julien Charpentier; Olivier Gontier; Fabienne Fieux; Bruno Mourvillier; Gilles Troché; Jean Reignier; Marie Françoise Dumay; Elie Azoulay; Bernard Reignier; Jean Carlet; Lilia Soufir
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

10.  Overview of medical errors and adverse events.

Authors:  Maité Garrouste-Orgeas; François Philippart; Cédric Bruel; Adeline Max; Nicolas Lau; B Misset
Journal:  Ann Intensive Care       Date:  2012-02-16       Impact factor: 6.925

View more
  2 in total

1.  Nurses' Perceptions on the Implementation of a Safe Drug Administration Protocol and Its Effect on Error Notification.

Authors:  Francisco Miguel Escandell-Rico; Juana Perpiñá-Galvañ; Lucía Pérez-Fernández; Ángela Sanjuán-Quiles; Piedras Albas Gómez-Beltrán; Juan Diego Ramos-Pichardo
Journal:  Int J Environ Res Public Health       Date:  2021-04-02       Impact factor: 3.390

2.  Medication-related interventions to improve medication safety and patient outcomes on transition from adult intensive care settings: a systematic review and meta-analysis.

Authors:  Richard S Bourne; Jennifer K Jennings; Maria Panagioti; Alexander Hodkinson; Anthea Sutton; Darren M Ashcroft
Journal:  BMJ Qual Saf       Date:  2022-01-18       Impact factor: 7.418

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.